Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer

被引:30
|
作者
Fakkert, Ingrid E. [1 ]
Abma, Elske Marije [2 ]
Westrik, Iris G. [3 ]
Lefrandt, Joop D. [3 ]
Wolffenbuttel, Bruce H. R. [4 ]
Oosterwijk, Jan C. [5 ]
Slart, Riemer H. J. A. [6 ]
van der Veer, Eveline [7 ]
de Bock, Geertruida H. [1 ]
Mourits, Marian J. E. [8 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Geriatr Med, Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Vasc Med, Groningen, Netherlands
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands
[6] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands
[7] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands
[8] Univ Groningen, Univ Med Ctr Groningen, Dept Gynaecol, Groningen, Netherlands
关键词
Genes; BRCA1; BRCA2; Ovariectomy; Osteoporosis; Fractures; Bone; POSTMENOPAUSAL WOMEN; LUMBAR SPINE; HYSTERECTOMY; MENOPAUSE; HEALTH; BRCA1; TIME; CARE;
D O I
10.1016/j.ejca.2014.11.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: Risk-reducing salpingo-oophorectomy (RRSO) reduces ovarian cancer risk in BRCA mutation carriers. RRSO is assumed to decrease bone mineral density (BMD) and increase fracture risk more than natural menopause. We aimed to compare BMD and fracture incidence after premenopausal RRSO to general population data and identify risk factors for low BMD and fractures after RRSO. Methods: In 212 women with RRSO at premenopausal age, BMD was measured by dual energy X-ray absorptiometry. Fractures and risk factors were assessed by self-administered questionnaire Fracture incidence after RRSO was compared to general practitioner data by using standardised incidence ratios (SIRs). Risk factors for low standardised BMD-scores and fractures were identified by regression analyses. Results: Median age at RRSO was 42 years (range 35-65) and duration of follow-up 5 years (2-8). Standardised lumbar spine (Z = 0.01, p = 0.870) and femoral neck BMD (Z = 0.15, p = 0.019) were not lower than population BMD. Higher age at time of RRSO and use of hormonal replacement therapy were associated with higher, and current smoking with lower standardised BMD-scores. Sixteen women reported 22 fractures. Fracture incidence was not higher than expected from the general population (all fractures: 25-44 years: SIR 2.12 [95% confidence interval (CI) 0.85-4.37]; 45-64 years: SIR 1.65 [95% CI 0.92-2.72]). Conclusion: Five years after RRSO, BMD and fracture incidence were not different than expected from the general population. Based on these data it appears safe not to intensively screen for osteoporosis within five years after RRSO, although prospective research on the long-term effects of RRSO on bone is warranted. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:400 / 408
页数:9
相关论文
共 50 条
  • [41] Effect of risk-reducing salpingo-oophorectomy on the quality of life in Korean BRCA mutation carriers
    Chae, Sumin
    Kim, Eun-Kyu
    Jang, Ye Rang
    Lee, Angela Soeun
    Kim, Seul Ki
    Suh, Dong Hoon
    Kim, Kidong
    No, Jae Hong
    Kim, Yong-Beom
    Kim, Sung-Won
    Kang, Eunyoung
    ASIAN JOURNAL OF SURGERY, 2021, 44 (08) : 1056 - 1062
  • [42] Stopping ovarian cancer screening in BRCA1/2 mutation carriers: Effects on risk management decisions & outcome of risk-reducing salpingo-oophorectomy specimens
    van Driel, Catheleine M. G.
    de Bock, Geertruida H.
    Arts, Henriette J. G.
    Sie, Aisha S.
    Hollema, Harry
    Oostervvijk, Jan C.
    Mourits, Marian J. E.
    MATURITAS, 2015, 80 (03) : 318 - 322
  • [43] Risk of cardiovascular disease among women carrying BRCA mutations after risk-reducing bilateral salpingo-oophorectomy: A population-based study
    do Valle, Helena Abreu
    Kaur, Paramdeep
    Kwon, Janice S.
    Cheifetz, Rona
    Dawson, Lesa
    Hanley, Gillian E.
    GYNECOLOGIC ONCOLOGY, 2021, 162 (03) : 707 - 714
  • [44] Risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 or BRCA2 mutation carriers: A systematic review and meta-analysis
    Wang, Yizi
    Song, Zixuan
    Zhang, Shitai
    Wang, Xiaoying
    Li, Peiwen
    EJSO, 2022, 48 (06): : 1209 - 1216
  • [45] Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis
    Manchanda, R.
    Burnell, M.
    Abdelraheim, A.
    Johnson, M.
    Sharma, A.
    Benjamin, E.
    Brunell, C.
    Saridogan, E.
    Gessler, S.
    Oram, D.
    Side, L.
    Rosenthal, A. N.
    Jacobs, I.
    Menon, U.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (05) : 527 - 536
  • [46] Discussing Sexuality With Women Considering Risk-Reducing Salpingo-oophorectomy: An International Survey of Current Practice in Gynecologic Oncology
    Tucker, Paige E.
    Bulsara, Max K.
    Salfinger, Stuart G.
    Tan, Jason Jit-Sun
    Green, Helena
    Cohen, Paul A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (07) : 1338 - 1344
  • [47] No signs of subclinical atherosclerosis after risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers
    van Bommel, Majke H. D.
    de Jong, Marieke Arts
    Steenbeek, Miranda P.
    Bots, Michiel L.
    van Westerop, Liselore L. M.
    Hopman, Maria T. E.
    Hoogerbrugge, Nicoline
    de Hullu, Joanne A.
    Maas, Angela H. E. M.
    JOURNAL OF CARDIOLOGY, 2021, 77 (06) : 570 - 575
  • [48] Concurrent uterine surgery and uptake of hormone therapy in patients undergoing bilateral salpingo-oophorectomy for risk-reducing or therapeutic indications
    Sasse, Simone A.
    Lee, Sarah S.
    Rajeev, Pournami
    Sharma, Sneha R.
    Kahan, Tamara
    Pothuri, Bhavana
    GYNECOLOGIC ONCOLOGY, 2023, 179 : 131 - 137
  • [49] Osteoporosis risk and management in BRCA1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy
    Garcia, Christine
    Lyon, Liisa
    Conell, Carol
    Littell, Ramey D.
    Powell, C. Bethan
    GYNECOLOGIC ONCOLOGY, 2015, 138 (03) : 723 - 726
  • [50] Impact of risk-reducing salpingo-oophorectomy on lipid determinants, HbA1c and CRP
    Vermeulen, R. F. M.
    van Altena, J. L.
    Gaarenstroom, K. N.
    van Beurden, M.
    Kieffer, J. K.
    Aaronson, N. K.
    Kenter, G. G.
    Korse, C. M.
    CLIMACTERIC, 2023, 26 (05) : 489 - 496